ArticleCardiology journal

IMPACT of PCSK9 inhibition on clinical outcome in patients during the inflammatory stage of the SARS-COV-2 infection: Rationale and protocol of the IMPACT-SIRIO 5 study.

Jacek Kubica et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.